Article Information
History
- May 17, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sahar Saeed1,*,
- Samra Uzicanin1,
- Antoine Lewin2,
- Ryanne Lieshout-Krikke3,
- Helen Faddy4,
- Christian Erikstrup5,
- Carla Osiowy6,
- Clive Seed4,
- Whitney Steele7,
- Katy Davidson8,
- Brian Custer9,
- Sheila O’Brien1 and
- On behalf of the Surveillance Risk Assessment and Policy (SRAP) sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion
- 1Epidemiology & Surveillance, Canadian Blood Services, Ottawa, Canada
- 2Surveillance & Biological Risk Assessment, Héma-Québec, Montreal Canada
- 3Department of Medical Affairs, Sanquin Blood Supply Foundation, Amsterdam, Netherlands
- 4School of Health and Behavioural Sciences, University of the Sunshine Coast, Petrie, Australia
- 5Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark
- 6National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
- 7Epidemiology and Surveillance Group, Scientific Affairs, American Red Cross, Rockville USA
- 8NHS Blood and Transplant /Public Health England Epidemiology Unit, London, England
- 9Research & Scientific Programs, Vitalant, San Francisco, USA
- ↵*Corresponding Author:
Sahar Saeed, MSc., PhD, Canadian Blood Services, 1800 Alta Vista Dr., Ottawa, ON, Canada K1G 4J5, sahar.saeed{at}blood.ca, 514-945-0224, Fax: 613-731-1411
Posted May 17, 2021.
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review
